Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma

A technology for T-2 and pancreatic cancer, applied in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve the problem that the research on T-2 toxin has not yet been found.

Active Publication Date: 2013-02-13
SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the research on T-2 toxin mainly focuses on its toxicity research and pathogenicity research on animals, and there is no report on the research on T-2 toxin used in the treatment of solid tumors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma
  • Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma
  • Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1: Experimental research on the therapeutic effect of T-2 toxin on pancreatic cancer

[0015] Human pancreatic cancer tissue fragments with a diameter of 2-3 mm were subcutaneously transplanted into mice. After the tumor grew to 6-7 mm, T-2 toxin dissolved in ethanol saline mixture was injected into the tumor at a dose of 2.5 mg / kg body weight. injection, and the control group was injected with normal saline. The size of the tumor was measured with a vernier caliper or a standard template on the 1st, 5th, 9th, 14th, 19th, and 24th day after injection, and the measurement lasted for 24 days. After 24 days of treatment, the tumor volume of the animals in the T-2 toxin group was only 52.19% of that in the control group.

Embodiment 2

[0016] Example 2: Experimental research on the therapeutic effect of T-2 toxin on lung cancer

[0017] Mouse Lewis lung cancer cells were placed in complete culture medium containing 10% fetal bovine serum and DMEM, at 37°C, 5% CO 2 Cultivate in an incubator, and replace the culture medium every 2-3 days. The cells grow adherently in a single layer, digested with 0.5% trypsin and passaged. After the total number of cells reaches the requirement, the number of living cells determined by the trypan blue exclusion method is greater than 95%, and the cell concentration is adjusted to 5×10 6 / ml, cell suspension spare C57BL / 6 pure line mice, male, 20, 6-8 weeks old, body weight (18±1) g. Inoculate subcutaneously in the axilla. Each mouse was inoculated with 0.2ml, and the cell count was 5×10 6 cells / ml. Mice were randomly divided into 2 groups, 10 in each group. In the control group, 2 ml of normal saline was injected into the tumor, and in the experimental group, T-2 toxin d...

Embodiment 3

[0021] Example 3: Experimental research on the therapeutic effect of T-2 toxin on liver cancer

[0022] Mouse H 22 Liver cancer cell lines, ICR mice peritoneal passage. Under aseptic conditions, the H 22 For liver cancer cells, adjust the cell concentration to 5×10 with normal saline 6 / ml, 20 detergent ICR mice, 6-8 weeks old, male, 18-22g, were randomly divided into 2 groups, 10 in each group. 0.2 ml of tumor cell suspension was inoculated subcutaneously in the left armpit. Seven days after the inoculation, the control group was injected with 2 ml of normal saline, and the experimental group was injected with T-2 toxin dissolved in ethanol-normal saline mixture at a dose of 2.0 mg / kg body weight. The long diameter (L) and short diameter (W) of the tumor were measured with a vernier caliper every other day after group administration, and the tumor volume and tumor growth inhibition rate were calculated. The results are shown in Table 2. The test results showed that T-2 t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses new application of T-2 toxin, namely application of T-2 toxin to preparing drugs for treating pancreatic carcinomas. The effective treatment amount of T-2 toxin is 0.1-20mg / Kg, preferably 0.5-8mg / Kg. The drugs are administrated by implantation, oral administration, intravenous injection, hypodermic injection and intramuscular injection, preferably intra-tumor injection. The inventor builds various solid tumor models and then examines the inhibiting effect of T-2 toxin on the tumors or tumor cells by carrying out intra-tumor injection or culture with cells on T-2 toxin. Experiments show that intra-tumor injection has confirmed curative effect on the tumors, especially the solid tumors hard to excised and drug administration through intra-tumor injection can further reduce the side effect range and degree of T-2 toxin, reduce the side effects of T-2 toxin and improve the inhibiting and killing effects of T-2 toxin on the tumor tissues.

Description

technical field [0001] The invention relates to the application of T-2 toxin in the preparation of medicine for treating pancreatic cancer. Background technique [0002] Tumor is one of the common diseases that threaten human health, second only to cardiovascular disease. The research on tumor has made great progress, and a variety of radiotherapy, chemotherapy and other methods have been developed to treat tumors. However, various drugs and therapies There are limitations, it is difficult to achieve a radical effect, and prone to drug resistance and side effects. The mortality rate of cancer still ranks first in various diseases. According to statistics, in 2006, 3 million people died of cancer in my country, and the incidence of cancer is still on the rise, and there is a trend of getting younger. According to statistics, in less than 20 years, the incidence of cancer in my country has increased by 69%, and the mortality rate has increased by 29.4%. Therefore, the study...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61P35/00
Inventor 厉保秋
Owner SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD